CutisPharma Revenue and Competitors

Boston, MA USA



Total Funding



Estimated Revenue & Valuation

  • CutisPharma's estimated annual revenue is currently $118.8M per year.(i)
  • CutisPharma received $Undisclosed in venture funding in January 2015.
  • CutisPharma's estimated revenue per employee is $281,400
  • CutisPharma's total funding is $20M.

Employee Data

  • CutisPharma has 422 Employees.(i)
  • CutisPharma grew their employee count by 17% last year.

CutisPharma's People

Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

What Is CutisPharma?

CutisPharma, Inc., based in Wilmington, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST® Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Three U.S. patents have been issued to the Company with several additional patents pending.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





CutisPharma News

2019-06-24 - Massachusetts company acquires pharmaceutical business with OP facility

Massachusetts pharmaceutical company CutisPharma Inc. has acquired Silvergate Pharmaceuticals Inc., creating a new, unified company ...

2019-03-26 - CutisPharma Continues Growth Trajectory with Opening of ...

WOBURN, Mass., March 26, 2019 /PRNewswire/ -- CutisPharma, Inc. announced today the opening of its new corporate headquarters in ...

2019-01-15 - CutisPharma Announces New Management Team ...

WILMINGTON, Mass., Jan. 15, 2019 /PRNewswire/ -- CutisPharma, Inc. announced today the appointments of Mike Radice as Chief ...

2015-01-07 - CutisPharma Raises Venture Capital and Debt Funding

CutisPharma, a Wilmington, Mass.-based developer of “value-added kits” for the compounding pharmacy market, raised an undisclosed amount of venture capital and debt funding. Ampersand Capital Partners made the investment while Silicon Valley Bank provided a senior credit facility from. In conju ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

CutisPharma Funding

DateAmountRoundLead InvestorsReference
2015-01-07$UndisclosedUndisclosedAmpersand Capital PartnersArticle